Iezzi Roberto, Kovacs Attila, Prenen Hans, Chevallier Patrick, Pereira Philippe L
Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia - Istituto di Radiologia, l.go A gemelli 8, 00168 Rome, Italy.
Università Cattolica del Sacro Cuore, Rome, Italy.
Eur J Radiol Open. 2020 May 13;7:100236. doi: 10.1016/j.ejro.2020.100236. eCollection 2020.
The last decade has seen important developments in the treatment of metastatic colorectal cancer (mCRC). In this scenario, interventional locoregional treatments could play an expanding role offering safe and effective integrated options in the continuum-of-care offering curative as well as palliative approaches. Based on ESMO guidelines, the toolbox of ablative treatments also includes intra-arterial palliative options, like chemoembolization, that can be offered as an alternative option in patients failing the available chemotherapeutic regimens. However, to date, there is still a limited use of chemoembolization in clinical practice. Based on this background, a comprehensive review of the methodologic and technical considerations as well as clinical indications and future perspectives seems to be useful with the aim to demonstrate the field's value of the procedure, highlight their advantages, and ensure an increased role in treatment management of patients with colorectal liver metastases.
过去十年间,转移性结直肠癌(mCRC)的治疗取得了重要进展。在这种情况下,介入性局部区域治疗可能会发挥越来越大的作用,在连续护理中提供安全有效的综合选择,包括根治性和姑息性治疗方法。根据欧洲肿瘤内科学会(ESMO)指南,消融治疗手段还包括动脉内姑息治疗选项,如化疗栓塞,可作为现有化疗方案治疗失败患者的替代选择。然而,迄今为止,化疗栓塞在临床实践中的应用仍然有限。基于这一背景,对方法学和技术考量、临床适应症及未来前景进行全面综述似乎很有必要,目的是证明该治疗方法在该领域的价值,突出其优势,并确保其在结直肠癌肝转移患者治疗管理中发挥更大作用。